Pending — not yet graded
“Bullish on Glenmark Pharmaceuticals futures, recommending a buy in the ₹2,480-2,490 range with a stop loss below ₹2,440 and targets of ₹2,560-2,600. The stock is in a clear uptrend, forming higher lows and highs, supported by long build-up and expected call unwinding from options data. ₹2,400 acts as strong support.”
Jay Thakkar’s track record: 5 graded calls · 95% CI 12–77%
Glenmark PharmaceuticalsBullishCalled 09 Sep 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.